ISSM | Movember

Making sexual health part of everyday prostate cancer care.

Prostate cancer treatment can affect sexual function, intimacy and relationships. The International Society for Sexual Medicine (ISSM) and Movember are working together to share the Guidelines for Sexual Health Care for Prostate Cancer Patients and help healthcare professionals apply them in practice.

Explore the Guidelines, practical tools and training to support patients and partners before, during and after treatment.

A man sitting next to a docter

of respondents in a prostate cancer survey reported that treatment negatively affected their sex lives.1

Introduction to the Guidelines

The Guidelines for Sexual Health Care for Prostate Cancer Patients bring together research evidence and expert opinion to help clinicians address sexual concerns, discuss treatment effects and support shared care decisions with patients and partners.

Watch Daniela Wittmann explain why The Guidelines were developed and how the ISSM & Movember partnership helps bring them into clinical practice.

Our Offerings and Resources

The ISSM & Movember partnership brings the vision and mission to life through expert-led lectures, interactive workshops, and innovative educational offerings. Explore our programs and discover how we’re making an impact.

Toolkit

Workshops

Webinars

Expert Videos

What Do Experts Say?

Upcoming Events

FAQ

This section provides answers to common questions about the ISSM & Movember partnership, available resources, and training opportunities for healthcare professionals. If you can’t find what you’re looking for, feel free to reach out at movember@issm.info.

This website serves as a central hub for healthcare professionals to access guideline-based resources on addressing sexual health in prostate cancer care. It provides practical tools to help integrate these discussions into clinical practice.

This website provides a wide range of educational materials to support healthcare professionals in integrating sexual health into prostate cancer care, including:

  • Expert video discussions featuring Key Opinion Leaders (KOLs) explaining key topics related to sexual health and rehabilitation.
  • Dedicated sessions at relevant meetings, where sexual health and prostate cancer care are addressed.
  • Advanced workshops at international sexual medicine meetings for hands-on skill development.
  • Webinars offering interactive learning opportunities with experts in the field.
  • The ISSM-Movember Toolkit – a collection of practical resources, including guideline summaries, clinician interviews, patient education materials, and a professional slide set.

The ISSM & Movember Toolkit is a structured online resource designed to help clinicians incorporate guideline-based sexual health discussions into patient care. It includes:

  • Guideline summaries for quick reference.
  • Clinician interviews demonstrating best practices for discussing sexual health with patients.
  • Patient education materials on sexual rehabilitation and treatment side effects.
  • A professional slide set to support peer education and professional presentations.

The materials on this website are practical and adaptable for various clinical settings. You can:

  • Use KOL video discussions to stay informed on best practices.
  • Apply clinician interviews to refine patient communication.
  • Download and share patient education materials during consultations.
  • Refer to guideline summaries for evidence-based recommendations.
  • Utilize the slide set for presentations and peer education.

The materials on this website are intended for healthcare professionals to support their clinical practice. While some patient education materials are available for clinicians to use in consultations, they are designed as tools for HCPs rather than direct-to-patient resources.

For patient-focused resources, including information on sexual health after prostate cancer, rehabilitation strategies, and support tools, visit the TrueNorth website: https://truenorth.movember.com/sex-after-prostate-cancer.